Provided by Tiger Trade Technology Pte. Ltd.

Myriad Genetics

3.22
+0.06001.90%
Pre-market: 3.05-0.1700-5.28%04:31 EDT
Volume:1.54M
Turnover:4.92M
Market Cap:307.83M
PE:-2.68
High:3.26
Open:3.15
Low:3.04
Close:3.16
52wk High:8.59
52wk Low:2.74
Shares:95.60M
Float Shares:79.40M
Volume Ratio:1.09
T/O Rate:1.94%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.2031
EPS(LYR):-3.9514
ROE:-32.54%
ROA:-8.59%
PB:1.01
PE(LYR):-0.81

Loading ...

Myriad Genetics Q2 Gross Margin 66.6%

THOMSON REUTERS
·
Jul 31

Myriad Genetics Reports Second Quarter 2026 Financial Results; Deploying New Initiatives Focused on Driving Increased Efficiency, Productivity and Scalability

THOMSON REUTERS
·
Jul 31

Myriad Genetics Inc Expected to Post a Loss of 6 Cents a Share - Earnings Preview

Reuters
·
Jul 29

Centene Appoints Cressey’s Paul Diaz to Board as Burdick Retires

Reuters
·
Jul 28

Myriad Genetics Schedules Q2 Earnings Conference Call

Reuters
·
Jul 23

Myriad Genetics to Release Second Quarter 2026 Financial Results on July 30, 2026

GlobeNewswire
·
Jul 23

Myriad Genetics Launches FirstGene® Multiple Prenatal Screen

GlobeNewswire
·
Jul 21

Myriad Says Meta-analysis Supports Prognostic Performance of Prolaris Biopsy Test in Localized Prostate Cancer

Reuters
·
Jul 02

Sera Prognostics Names Former Myriad Genetics CEO Mark Capone to Board

Reuters
·
Jul 01

Myriad Genetics Announces Resignation of Board Member Skovronsky

TIPRANKS
·
Jun 23

Myriad Genetics says MONITOR-Breast study supports Precise MRD ctDNA test in neoadjuvant monitoring

Reuters
·
Jun 23

Myriad Genetics Expands Availability of Precise MRD™ for Colorectal, Renal and Breast Cancers, Supported by New Publication

GlobeNewswire
·
Jun 23

Myriad Genetics director Daniel Skovronsky resigns from board

Reuters
·
Jun 23

3 Penny Stocks With Market Caps Over $400M To Consider

Simply Wall St.
·
Jun 22

Living Longer Is Big Business. These Stocks Will Benefit. -- Barrons.com

Dow Jones
·
Jun 19

Myriad Genetics director Rashmi Kumar sells 15,000 shares worth $66,843

Reuters
·
Jun 10

Myriad Genetics Holds 2026 Annual Meeting and Approves Plans

TIPRANKS
·
Jun 05

Myriad Genetics shareholders approve 4 million-share increase to employee stock purchase plan

Reuters
·
Jun 05

Press Release: Myriad Genetics Names Raj Jampa as New Chief Technology Officer

Dow Jones
·
Jun 02

Myriad Genetics reports interim MONSTAR-SCREEN-3 data showing Precise MRD test prognostic value across cancers at ASCO 2026

Reuters
·
May 27